FDA sends Procter & Gamble a warning

September 18, 2007

The U. S. Food and Drug Administration has warned the Procter & Gamble Co. about claims it makes for its Vicks Early Defense Foaming Hand Sanitizer.

The agency said the product's claims and directions for use cause it to be an unapproved new drug under the Federal Food, Drug, and Cosmetic Act.

The FDA specifically citied P&G for promoting Early Defense for use by schoolchildren to prevent colds and to provide antimicrobial activity for up to three hours. Officials said the product has not been proven safe and effective for such claims.

Under its drug monograph system, the FDA allows OTC drugs to be marketed without first obtaining agency approval in certain circumstances. Such drugs must comply with applicable standards regarding monographs that specify conditions for the drugs' labeling and formulation.

In the Procter & Gamble case, the Cincinnati-headquartered company's claims the product prevents colds and provides up to three hours of antimicrobial activity are not allowed.

Copyright 2007 by United Press International

Explore further: FDA approves first pill aimed at boosting female libido

Related Stories

FDA approves first pill aimed at boosting female libido

August 19, 2015

The Food and Drug Administration has approved the first prescription drug designed to boost sexual desire in women, a milestone long sought by a pharmaceutical industry eager to replicate the blockbuster success of impotence ...

Female libido drug remains in limbo (Update)

December 11, 2013

The 15-year search for a pill that boosts sexual desire in women has hit another roadblock, raising questions about the future of efforts to develop a female equivalent to Viagra.

US looks to reboot nonprescription drug system

February 21, 2014

The U.S. Food and Drug Administration is seeking to revamp its system for regulating hundreds of over-the-counter drugs, saying the decades-old process is not flexible enough to keep pace with modern medical developments.

Recommended for you

Study shows blood products unaffected by drone trips

December 7, 2016

In what is believed to be the first proof-of-concept study of its kind, Johns Hopkins researchers have determined that large bags of blood products, such as those transfused into patients every day, can maintain temperature ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.